glp 1 based therapy for diabetes GLP-1 Agonist Center GLP-1 Medications for Weight Loss:

Activation of GLP-1R in the PVN stimulates the release of oxytocin, which exerts anorexigenic effects [13]

"Transcranial Photobiomodulation in the Management of Chronic Migraine: A Review of Mechanisms." The Journal of Headache and Pain , 20(1), 1-12

In patients with PD and coexisting type 2 diabetes, GLP-1 receptor agonists offer dual therapeutic benefits, addressing both metabolic and neurodegenerative mechanisms

doi: 10.1111/jocd.13676

This work fills that gap in knowledge by demonstrating that a brief early-life BPA exposure, even at low concentrations, is sufficient to cause persistent adverse effects

Serious side effects are rare but possible